[1]
Andersson, J. et al. 2002. A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden. Acta Oncologica. 41, 3 (Jan. 2002), 276–281. DOI:https://doi.org/10.1080/02841860260088827.